Abcellera Biologics Stock Market Value
| ABCL Stock | USD 2.72 0.05 1.87% |
| Symbol | Abcellera |
Abcellera Biologics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.61) | Revenue Per Share 0.112 | Quarterly Revenue Growth (0.01) | Return On Assets (0.13) |
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Abcellera Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Abcellera Biologics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Abcellera Biologics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Abcellera Biologics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Abcellera Biologics or generate 0.0% return on investment in Abcellera Biologics over 30 days. Abcellera Biologics is related to or competes with Hepion Pharmaceuticals, Krystal Biotech, CureVac NV, Vir Biotechnology, PTC Therapeutics, Sarepta Therapeutics, and Iovance Biotherapeutics. AbCellera Biologics Inc. develops antibody discovery platform More
Abcellera Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Abcellera Biologics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Abcellera Biologics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.16 | |||
| Information Ratio | 0.0012 | |||
| Maximum Drawdown | 22.7 | |||
| Value At Risk | (5.47) | |||
| Potential Upside | 6.25 |
Abcellera Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abcellera Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Abcellera Biologics' standard deviation. In reality, there are many statistical measures that can use Abcellera Biologics historical prices to predict the future Abcellera Biologics' volatility.| Risk Adjusted Performance | 0.0309 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.39) | |||
| Sortino Ratio | 0.0014 | |||
| Treynor Ratio | 0.0867 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abcellera Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Abcellera Biologics Backtested Returns
As of now, Abcellera Stock is slightly risky. Abcellera Biologics secures Sharpe Ratio (or Efficiency) of 0.0225, which signifies that the company had a 0.0225% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Abcellera Biologics, which you can use to evaluate the volatility of the firm. Please confirm Abcellera Biologics' mean deviation of 2.81, and Risk Adjusted Performance of 0.0309 to double-check if the risk estimate we provide is consistent with the expected return of 0.0842%. Abcellera Biologics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.2, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Abcellera Biologics will likely underperform. Abcellera Biologics right now shows a risk of 3.75%. Please confirm Abcellera Biologics sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to decide if Abcellera Biologics will be following its price patterns.
Auto-correlation | 0.25 |
Poor predictability
Abcellera Biologics has poor predictability. Overlapping area represents the amount of predictability between Abcellera Biologics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Abcellera Biologics price movement. The serial correlation of 0.25 indicates that over 25.0% of current Abcellera Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Abcellera Biologics lagged returns against current returns
Autocorrelation, which is Abcellera Biologics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Abcellera Biologics' stock expected returns. We can calculate the autocorrelation of Abcellera Biologics returns to help us make a trade decision. For example, suppose you find that Abcellera Biologics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Abcellera Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Abcellera Biologics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Abcellera Biologics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Abcellera Biologics stock over time.
Current vs Lagged Prices |
| Timeline |
Abcellera Biologics Lagged Returns
When evaluating Abcellera Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Abcellera Biologics stock have on its future price. Abcellera Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Abcellera Biologics autocorrelation shows the relationship between Abcellera Biologics stock current value and its past values and can show if there is a momentum factor associated with investing in Abcellera Biologics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Abcellera Biologics Correlation, Abcellera Biologics Volatility and Abcellera Biologics Alpha and Beta module to complement your research on Abcellera Biologics. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Abcellera Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.